A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Abbott Laboratories stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 400,535 shares of ABT stock, worth $51.4 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
400,535
Previous 356,729 12.28%
Holding current value
$51.4 Million
Previous $37.1 Million 23.19%
% of portfolio
0.11%
Previous 0.1%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$100.07 - $118.13 $4.38 Million - $5.17 Million
43,806 Added 12.28%
400,535 $45.7 Million
Q2 2024

Jul 29, 2024

BUY
$100.73 - $112.44 $2.51 Million - $2.8 Million
24,892 Added 7.5%
356,729 $37.1 Million
Q1 2024

May 08, 2024

BUY
$109.52 - $120.96 $880,978 - $973,002
8,044 Added 2.48%
331,837 $37.7 Million
Q4 2023

Feb 09, 2024

SELL
$90.19 - $110.4 $1.39 Million - $1.7 Million
-15,385 Reduced 4.54%
323,793 $35.6 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $5.34 Million - $6.41 Million
-55,895 Reduced 14.15%
339,178 $32.8 Million
Q2 2023

Aug 08, 2023

SELL
$100.78 - $112.29 $2.34 Million - $2.6 Million
-23,187 Reduced 5.54%
395,073 $43.1 Million
Q1 2023

May 08, 2023

SELL
$96.86 - $114.01 $20.4 Million - $24 Million
-210,824 Reduced 33.51%
418,260 $42.4 Million
Q4 2022

Feb 09, 2023

BUY
$95.06 - $111.52 $25.3 Million - $29.6 Million
265,643 Added 73.09%
629,084 $69.1 Million
Q3 2022

Nov 10, 2022

SELL
$96.76 - $112.03 $14.8 Million - $17.2 Million
-153,202 Reduced 29.65%
363,441 $35.2 Million
Q2 2022

Aug 04, 2022

BUY
$102.07 - $123.37 $12.9 Million - $15.6 Million
126,505 Added 32.43%
516,643 $56.1 Million
Q1 2022

May 12, 2022

SELL
$114.02 - $139.04 $42.5 Million - $51.8 Million
-372,562 Reduced 48.85%
390,138 $46.2 Million
Q4 2021

Feb 09, 2022

BUY
$115.53 - $141.46 $6.72 Million - $8.22 Million
58,130 Added 8.25%
762,700 $107 Million
Q3 2021

Nov 08, 2021

SELL
$116.66 - $129.06 $43,397 - $48,010
-372 Reduced 0.05%
704,570 $83.2 Million
Q2 2021

Aug 05, 2021

BUY
$105.79 - $124.53 $5.76 Million - $6.78 Million
54,475 Added 8.37%
704,942 $81.7 Million
Q1 2021

May 05, 2021

BUY
$108.84 - $128.23 $6.73 Million - $7.93 Million
61,826 Added 10.5%
650,467 $78 Million
Q4 2020

Feb 12, 2021

BUY
$105.0 - $114.42 $6.75 Million - $7.35 Million
64,266 Added 12.26%
588,641 $64.5 Million
Q3 2020

Nov 09, 2020

SELL
$91.64 - $111.29 $18.2 Million - $22.1 Million
-198,355 Reduced 27.45%
524,375 $57.1 Million
Q2 2020

Aug 04, 2020

SELL
$76.57 - $98.0 $5.85 Million - $7.49 Million
-76,421 Reduced 9.56%
722,730 $66.1 Million
Q1 2020

May 12, 2020

SELL
$62.82 - $91.86 $187,580 - $274,293
-2,986 Reduced 0.37%
799,151 $63.1 Million
Q4 2019

Feb 11, 2020

BUY
$78.51 - $87.4 $9.92 Million - $11 Million
126,412 Added 18.71%
802,137 $69.7 Million
Q3 2019

Nov 12, 2019

BUY
$81.84 - $88.74 $2 Million - $2.17 Million
24,447 Added 3.75%
675,725 $56.5 Million
Q2 2019

Aug 02, 2019

BUY
$72.88 - $85.0 $7.6 Million - $8.86 Million
104,263 Added 19.06%
651,278 $54.8 Million
Q1 2019

Apr 26, 2019

BUY
$66.22 - $80.06 $4.01 Million - $4.85 Million
60,539 Added 12.44%
547,015 $43.7 Million
Q4 2018

Feb 13, 2019

SELL
$65.56 - $74.27 $50.3 Million - $57 Million
-766,993 Reduced 61.19%
486,476 $34.6 Million
Q3 2018

Nov 13, 2018

BUY
$60.81 - $73.36 $35.1 Million - $42.3 Million
577,175 Added 85.34%
1,253,469 $92 Million
Q2 2018

Aug 01, 2018

BUY
$57.57 - $63.54 $2.45 Million - $2.7 Million
42,528 Added 6.71%
676,294 $41.2 Million
Q1 2018

May 07, 2018

SELL
$56.27 - $63.62 $8.57 Million - $9.69 Million
-152,288 Reduced 19.37%
633,766 $38 Million
Q4 2017

Feb 01, 2018

SELL
$53.68 - $57.47 $7.9 Million - $8.46 Million
-147,175 Reduced 15.77%
786,054 $44.9 Million
Q3 2017

Nov 02, 2017

BUY
$48.06 - $53.64 $44.9 Million - $50.1 Million
933,229
933,229 $49.8 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $225B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Bnp Paribas Asset Management Holding S.A. Portfolio

Follow Bnp Paribas Asset Management Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.